2599 related articles for article (PubMed ID: 19463352)
1. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
Bhatt NS; Solhpour A; Balan P; Barekatain A; McCarthy JJ; Sdringola S; Denktas AE; Smalling RW; Anderson HV
Am J Cardiol; 2013 Jun; 111(11):1576-9. PubMed ID: 23490028
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
Solhpour A; Chang KW; Balan P; Cai C; Sdringola S; Denktas AE; Smalling RW; Anderson HV
Am J Cardiol; 2014 Jan; 113(1):60-3. PubMed ID: 24207074
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
6. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
Mehta RH; Ou FS; Peterson ED; Shaw RE; Hillegass WB; Rumsfeld JS; Roe MT;
JACC Cardiovasc Interv; 2009 Jan; 2(1):56-64. PubMed ID: 19463399
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M
Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
13. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
[TBL] [Abstract][Full Text] [Related]
15. Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction.
Geng W; Tian X; Fu X; Wang P; Wang Y; Wang X; Li W; Liu X
Coron Artery Dis; 2013 May; 24(3):238-43. PubMed ID: 23358446
[TBL] [Abstract][Full Text] [Related]
16. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
17. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
[TBL] [Abstract][Full Text] [Related]
19. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
